The feasibility and responsiveness of the health utilities index in patients with early-stage breast cancer: A prospective longitudinal study

被引:14
|
作者
Lovrics, Peter J. [1 ,2 ]
Cornacchi, Sylvie D. [1 ,2 ]
Barnabi, Francesco [1 ]
Whelan, Tim [3 ,4 ,5 ]
Goldsmith, Charles H. [2 ,3 ,6 ]
机构
[1] McMaster Univ, Dept Surgery Hamilton Hlth Sci & St Josephs Hlthc, Hamilton, ON L8N 4A6, Canada
[2] McMaster Univ, Surg Outcomes Res Ctr, Hamilton, ON, Canada
[3] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[4] McMaster Univ, Juravinski Canc Ctr, Dept Med, Hamilton, ON, Canada
[5] McMaster Univ, Juravinski Canc Ctr, Support Canc Care Res Unit, Hamilton, ON, Canada
[6] Father Sean Sullivan Res Ctr, Biostat Unit, St Josephs Hlthcare, Hamilton, ON, Canada
关键词
breast cancer; health utilities index; quality of life; responsiveness; SF-36;
D O I
10.1007/s11136-007-9305-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background The health utilities index (HUI3) is a health measurement instrument based on individuals' preferences for different health states. Breast cancer (BC) is common, with a high proportion of long-term survivors, making evaluation of treatment effects important. Feasibility and responsiveness of HUI3 was compared to the short-form 36 (SF-36) in patients with BC. Methods HUI3 and SF-36 were administered eight times: at initial surgical consultation, 1 week before surgery; 1 week, 3, 6, 12, 18, and 24 months after surgery. Effect size, analysis of variance, and Pearson product moment correlations were calculated. BC data were compared to normative values. Results Eighty-five patients were enrolled. Ninety-one percent of planned assessments were completed. HUI3 showed significant responsiveness (P < 0.01) after surgery and during recovery. HUI3 scores correlated with SF-36 scores. Comparison to normative data demonstrated the significant detrimental effect of BC diagnosis. Results showed long-term effects of treatment on physical health and positive effects on mental/emotional health in BC survivors. Conclusion(s) HUI3 was found to be feasible and responsive in our cohort of BC patients. Changes in HUI3 values over time, and compared to normative data, paralleled SF-36 scores. HUI3 is a valuable tool in health-related quality of life and cost-utility studies in patients with BC.
引用
收藏
页码:333 / 345
页数:13
相关论文
共 50 条
  • [31] A prospective single-institution study of intraoperative radiotherapy (IORT) for early-stage breast cancer
    My-Lien Nguyen
    Pius, Patricia
    Dooley, William
    Squires, Ronald
    Algan, Ozer
    Chen, Yong
    Johnson, Daniel
    Henson, Christina
    BREAST JOURNAL, 2021, 27 (03): : 231 - 236
  • [32] Early-stage breast cancer is not associated with the risk of marital dissolution in a large prospective study of women
    Laitala, V. S.
    Saarto, T.
    Einio, E. K.
    Martikainen, P.
    Silventoinen, K.
    BRITISH JOURNAL OF CANCER, 2015, 113 (03) : 543 - 547
  • [33] Early-stage breast cancer is not associated with the risk of marital dissolution in a large prospective study of women
    V S Laitala
    T Saarto
    E K Einiö
    P Martikainen
    K Silventoinen
    British Journal of Cancer, 2015, 113 : 543 - 547
  • [34] Metabolic syndrome and early-stage breast cancer outcome: Results from a prospective observational study
    Buono, G.
    Crispo, A.
    Giuliano, M.
    Rea, C. G.
    Forestieri, V.
    Lauria, R.
    De Placido, P.
    De laurentiis, M.
    Pacilio, C.
    Grimaldi, M.
    Nocerino, F.
    Montella, M.
    De Placido, S.
    Arpino, G.
    CANCER RESEARCH, 2019, 79 (04)
  • [35] Determinants of Breast-Conserving Therapy in Early-Stage Breast Cancer Patients: A Nationwide Study
    Machuca, Maria Paz Galeano
    Wu, Wen-Ching
    Yu, Ben-Long
    Cheng, Chih-Tao
    CLINICAL BREAST CANCER, 2022, 22 (04) : E473 - E479
  • [36] Radiotherapy of early-stage breast cancer
    Yu, Cedric X.
    PRECISION RADIATION ONCOLOGY, 2023, 7 (01): : 67 - 79
  • [37] Denosumab in early-stage breast cancer
    Brandao, Mariana
    Debiasi, Marcio
    de Azambuja, Evandro
    LANCET ONCOLOGY, 2019, 20 (05): : E234 - E235
  • [38] Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
    Beaver, Julia A.
    Jelovac, Danijela
    Balukrishna, Sasidharan
    Cochran, Rory L.
    Croessmann, Sarah
    Zabransky, Daniel J.
    Wong, Hong Yuen
    Toro, Patricia Valda
    Cidado, Justin
    Blair, Brian G.
    Chu, David
    Burns, Timothy
    Higgins, Michaela J.
    Stearns, Vered
    Jacobs, Lisa
    Habibi, Mehran
    Lange, Julie
    Hurley, Paula J.
    Lauring, Josh
    VanDenBerg, Dustin A.
    Kessler, Jill
    Jeter, Stacie
    Samuels, Michael L.
    Maar, Dianna
    Cope, Leslie
    Cimino-Mathews, Ashley
    Argani, Pedram
    Wolff, Antonio C.
    Park, Ben Ho
    CLINICAL CANCER RESEARCH, 2014, 20 (10) : 2643 - 2650
  • [39] Cardiorespiratory Fitness in Patients With Early-Stage Breast Cancer and Radiation Therapy-Related Fatigue: A Prospective Pilot Study
    Leeman, Jonathan E.
    Lapen, Kaitlyn
    Fuchs, Hannah E.
    Goner, Mithat
    Michalski, Meghan
    Gillespie, Erin F.
    Jones, Lee W.
    Mccormick, Beryl
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (04): : 1060 - 1065
  • [40] Obesity and early-stage breast cancer
    Chlebowski, RT
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) : 1345 - 1347